106961-33-5

基本信息
N,N,6-三甲基-2-(4-甲基苯基)咪唑并[1,2-Α]吡啶-3-甲胺
N,N-二甲基-1-(6-甲基-2-(對(duì)甲苯)咪唑并[1,2-A]吡啶-3-基)甲胺
Zolpidem Impurity 67
imidazo[1,2-a]pyridin-3-yl)
N,N-Dimethyl-1-(6-methyl-2-(p-tolyl)
DIMETHYL-(6-METHYL-2-P-TOLYL-IMIDAZO[1,2-A]PYRIDIN-3-YLMETHYL)-AMINE
Imidazo[1,2-a]pyridine-3-methanamine, N,N,6-trimethyl-2-(4-methylphenyl)-
3-(DiMethylaMinoMethyl)-6-Methyl-2-(4-Methylphenyl)iMidazo[1,2-a]pyridine
N,N-dimethyl-1-(6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)methanamine
物理化學(xué)性質(zhì)
制備方法

50-00-0
![6-甲基-2-(4-甲基苯基)咪唑[1,2-a]吡啶](/CAS/GIF/88965-00-8.gif)
88965-00-8

124-40-3
![N,N,6-三甲基-2-(4-甲基苯基)咪唑并[1,2-Α]吡啶-3-甲胺](/CAS/GIF/106961-33-5.gif)
106961-33-5
步驟(i):制備N,N-二甲基-1-(6-甲基-2-(對(duì)甲苯基)咪唑并[1,2-a]吡啶-3-基)甲胺(8)。在攪拌下,將6-甲基-2-(4-甲基苯基)咪唑并[1,2-a]吡啶(200克,0.92摩爾)溶解于乙酸(985毫升)中。將反應(yīng)混合物冷卻至0-5℃,緩慢加入40%二甲胺水溶液(157克,1.39摩爾),隨后加入多聚甲醛(36.11克,1.20摩爾)。在50-55℃下攪拌反應(yīng)混合物3-4小時(shí),隨后在減壓下除去乙酸。加入水(1.5升),通過(guò)硅藻土墊過(guò)濾,并通過(guò)滴加30%氫氧化鈉溶液將濾液堿化至pH 8.0-8.5。過(guò)濾得到灰白色固體,依次用水(500毫升)和己烷(200毫升)洗滌。將固體在烘箱中干燥至恒重,得到N,N-二甲基-1-(6-甲基-2-(對(duì)甲苯基)咪唑并[1,2-a]吡啶-3-基)甲胺(8)230克,產(chǎn)率91.6%,純度93.5%。熔點(diǎn)范圍:137.9-141.5℃。IR光譜(cm^-1):2944, 2809, 2761, 1502, 1454, 1389, 1018, 829, 799。1H NMR(400 MHz, CDCl3):δ 2.25(s, 6H), 2.36(s, 3H), 2.40(s, 3H), 3.84(s, 2H), 7.04(dd, J = 9.1 Hz, J = 1.6 Hz, 1H), 7.25(d, J = 7.9 Hz, 2H), 7.52(d, J = 9.1 Hz, 1H), 7.69(d, J = 8.0 Hz, 2H), 8.10(s, 1H)。質(zhì)譜(m/z):280.4(M + H)+。
參考文獻(xiàn):
[1] Patent: WO2009/7995, 2009, A1. Location in patent: Page/Page column 11; 13-14; 15-17
[2] Farmaco, 1991, vol. 46, # SUPPL. 1, p. 277 - 288
[3] Acta Poloniae Pharmaceutica - Drug Research, 2001, vol. 58, # 1, p. 43 - 52
[4] Patent: US2007/27180, 2007, A1. Location in patent: Page/Page column title page; sheet 1; 6